Common Contracts
3 similar Extension Option Rider contracts by Applied Molecular Transport Inc., Applied Molecular Transport LLC, Turning Point Therapeutics, Inc.
SUMMARY OF BASIC LEASE INFORMATIONExtension Option Rider • May 18th, 2020 • Applied Molecular Transport Inc. • Pharmaceutical preparations
This Lease, which includes the preceding Summary and the exhibits attached hereto and incorporated herein by this reference (the Lease, the Summary and the exhibits to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between AP3-SF2 CT SOUTH, LLC, a Delaware limited liability company (“Landlord”), and APPLIED MOLECULAR TRANSPORT INC., a Delaware corporation (“Tenant”).
SUMMARY OF BASIC LEASE INFORMATIONExtension Option Rider • February 13th, 2020 • Applied Molecular Transport LLC • Pharmaceutical preparations
This Lease, which includes the preceding Summary and the exhibits attached hereto and incorporated herein by this reference (the Lease, the Summary and the exhibits to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between AP3-SF2 CT SOUTH, LLC, a Delaware limited liability company (“Landlord”), and APPLIED MOLECULAR TRANSPORT INC., a Delaware corporation (“Tenant”).
SUMMARY OF BASIC LEASE INFORMATIONExtension Option Rider • March 21st, 2019 • Turning Point Therapeutics, Inc. • Pharmaceutical preparations
This Lease, which includes the preceding Summary and the exhibits attached hereto and incorporated herein by this reference (the Lease, the Summary and the exhibits to be known sometimes collectively hereafter as the “Lease”), dated as of the date set forth in Section 1 of the Summary, is made by and between WALTON TORREY OWNER A, L.L.C., a Delaware limited liability company (“Landlord”), and TP THERAPEUTICS, INC., a Delaware corporation “Tenant”).
